Pillstats
Rx only · Injection · Intravenous

Ifosfamide

Ifosfamide

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US2 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCL01AA06
RxCUI (US)5657
US makers1 labelers
Packages2
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

39771161542025 Q12025 Q22025 Q32025 Q42026 Q1
15
Rx · 2026 Q1
920
Units dispensed
-80%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Hikma Pharmaceuticals USA Inc.unknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jun 12, 2026
    SHORTAGEDrug shortage: Ifosfamide Injection (Hikma Pharmaceuticals USA, Inc.)

    Ifosfamide Injection — reported in shortage by Hikma Pharmaceuticals USA, Inc.. Therapeutic category: Oncology, Pediatric.